You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
A new GeoMx Digital Spatial Profiler assay will have up to 30 protein targets and will be validated for potential use as a laboratory-developed test.
Researchers built a systematic map of protein-drug interactions to investigate the behaviors of cancer cells and the dependencies of treatment responses.
The deal enables Genosity to add Olink's proteomics technology with next-generation sequencing readout to its repertoire of services.
IsoPlexis' single-cell proteomics products will be made available to researchers in these countries through Medquest.
New studies suggest levels of a blood protein that may reflect whether someone has Alzheimer's disease.
At the AACR annual meeting, researchers shared detection rate data for multi-cancer screening tests from Grail and Thrive Earlier Detection.
The company said it will use the financing to support the commercialization of its automated biological testing platform for academic and clinical research.
The companies will use Freenome's platform to identify cancer patients who are most likely to respond to treatment with ADC's loncastuximab tesirine.
Researchers focused on using existing computational methods to fill in gaps in the human microbiome without reference genomes.
Quanterix said that the acquisition will secure the supply of neurofilament light antibodies that are critical to its Simoa assays and services.
SARS-CoV-2 vaccine developers are evaluating further vaccine doses as well as modified doses to keep up with new viral variants, according to CNN.
The New York Times reports that a new viral variant of concern has been identified in New York City.
In Nature this week: spatiotemporally resolved map of the human cell cycle, folding single-cell RNA sequencing into cancer drug studies, and more.
According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.